Sr One Capital Management »

Oric Pharmaceuticals shares owned by Sr One Capital Management

Quarter-by-quarter ownership of Oric Pharmaceuticals (ORIC) shares owned by Sr One Capital Management from 13F filings

Historical chart of Sr One Capital Management investment in Oric Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Oric Pharmaceuticals held by Sr One Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oric Pharmaceuticals by Sr One Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $54M 4.5M 12.00
2025-06-30 $46M 4.5M 10.15

More positions owned by Sr One Capital Management

Arcellx Common Stock (ACLX)
CRISPR Therapeutics Common Shares (CRSP)
Zenas BioPharma Common Stock (ZBIO)
Mineralys Therapeutics Common Stock (MLYS)
ORIC Pharmaceuticals Common Stock (ORIC)
Design Therapeutics Common Stock (DSGN)
ARS Pharmaceuticals Common Stock (SPRY)
Oruka Therapeutics Common Stock (ORKA)
Alumis Common Stock (ALMS)
Nkarta Common Stock (NKTX)
Oculis Holding Ordinary Shares (OCS)
enGene Holdings Common Shares (ENGN)

View all positions for Sr One Capital Management

Top funds holding Oric Pharmaceuticals

Nextech Invest
EcoR1 Capital
VR Adviser
Viking Global Investors
Pfizer
BlackRock
Vanguard Group
Sr One Capital Management
Alkeon Capital Management
NEA Management Company
OrbiMed Advisors
Column Group
Vivo Capital
Point72 Asset Management
FMR

View all funds holding Oric Pharmaceuticals